Exercises to Enhance Uterus Involution

NCT05860023 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2023-05-16

No results posted yet for this study

Summary

The goal of this randomized controlled study was to compare the effect of aerobic exercise and pelvic floor muscle strengthening exercises on uterus involution. In the scope of study following questions will be answered at the end of the study. First which of the exercise type is more effective to enhance uterus involution? Secondly, does exercises induce changes in lactation rate during the study period? Thirdly, does exercises improve the experienced pain? Study will be consisted of three groups as control group, pelvic floor exercise group and aerobic exercise group. Control group will take routine gynaecological treatment. Pelvic floor muscle strengthening exercise group will attend to seven day pelvic floor strengthening exercise programme. Aerobic exercise group will attend to seven day aerobic exercise programme consisting of walking.

Conditions

  • Uterus Involution

Interventions

OTHER

Exercise

Individuals in the experimental group will be asked to perform aerobic exercise or pelvic floor muscle strengthening exercises.

Sponsors & Collaborators

  • Bitlis Eren University

    lead OTHER

Principal Investigators

  • Ömer Dursun, Asst. Prof. · Bitlis Eren University

  • Burçhan Aydıner, M.D. · Yuzuncu Yıl University

  • Erhan Dincer, M.Sc. · Bitlis Eren University

  • Özal Keleş, Ph.D. · Bitlis Eren University

  • Yasemin Aslan Keleş, M.Sc. · Biruni University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-15
Primary Completion
2023-09-15
Completion
2023-10-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05860023 on ClinicalTrials.gov